Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 11 -20 of 101 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


11.		Phase III Combination Chemotherapy with MOPP (NM/VCR/PCB/PRED) Adjuvant to Radiotherapy for Hodgkin's Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				under 61								WCG-135

Last Modified: 12/1/1997


12.		Phase III Extended vs Involved Field Radiotherapy with or without MOPP Chemotherapy for Childhood Hodgkin's Disease (Summary Last Modified 12/97 km)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				under 18				NCI				CCG-541 CLB-7691, POG-7660


13.		Phase III Combination Chemotherapy and Hormone Therapy with NM/VCR/PCB/PRED plus Radiotherapy for Stage III Hodgkin's Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								MDAR-37


14.		Phase III Radiotherapy plus MOPP (NM/VCR/PCB/PRED) and ABVD (ADR/BLEO/VBL/DTIC) for Stage I/II Hodgkin's Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								MDA-RT-8001


15.		Phase III Evaluation of MOPP Chemotherapy in the Treatment of Localized Medulloblastoma or Ependynoma in Children (Grade I/II/III/IV) (Summary last modified 06/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				1 to 21				NCI				POG-7909 POG-7909


16.		Phase III Chemotherapy for Stage III/IV non-Hodgkin's Lymphomas with ProMACE (CTX/ADR/VP-16/PRED/MTX) and MOPP (NM/VCR/PCB/PRED)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				under 65								NCI-78-C-34 NCI-MB-93


17.		Phase III Chemotherapy with ADR/CTX/CACP Followed by Orchiectomy or Hormone Therapy with DES for Chemotherapy Failures with Metastatic Prostatic Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				under 70								NCI-78-C-56 NCI-NMOB-814

Last Modified: 1/25/2008


18.		Phase III Study of MOPP (NM/VCR/PCB/PRED) vs ABVD (ADR/BLEO/VBL/DTIC) vs Alternating MOPP and ABVD for Stage III/IV Hodgkin's Disease and for Selected Patients with Stage I/II Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				16 and over				NCI				CLB-8251 CALGB-8251

Last Modified: 3/1/1991


19.		Phase III Chemotherapy with MOPP (NM/VCR/PCB/PRED) vs Radiotherapy for Early Stage I/II Hodgkin's Disease (Summary Last Modified 03/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				14 and over				NCI				BRMP-8904 UMCC-7824, NCI-79-C-143, NCI-MB-133, NCI-MB-ROB-133, NCI-T83-1467N, T83-1467

Last Modified: 4/1/1989


20.		Phase III Observation plus Palliative Radiotherapy vs Intensive Chemotherapy for Previously Untreated Nodular Lymphomas and Diffuse Well-Differentiated Lymphocytic Lymphomas (Summary Last Modified 04/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over								BRMP-8903 NCI-78-C-145, NCI-MB-110, NCI-N82-522, N82-0522

Select All on One Page


					< Previous 1 2 3 4 5 Next >

| | | | | | | |

A Service of the National Cancer Institute